The first thing is that there has been great collaboration between the federal government and provincial governments on some of the things they have put in place right now. The income stability programs for our staff and for all the workers in Canada and things along those lines have been a significant plus and have had a great impact for our community members and the employees we have here at Osler.
As I mentioned in my submission, it's about learning lessons from the past and having plans in place, and specifically having plans in place for personal protective equipment. Suppliers and the supply chain are one of the main things we are challenged with right now.
The other thing is this. I know we spoke about what's happening with international travellers coming to the airport. One of the biggest issues that we face here being so close to the biggest international airport in Canada was that both Canadian and non-Canadian passengers were getting off the plane and telling us that the only people who were asking them questions or screening them were border services agents. I think that was a bit of a weakness in our process, in that smaller countries have public health workers at the gates to check temperatures or ask questions to isolate at-risk patients right at the point of entry.
The last thing I want to talk about is something I mentioned earlier: our drug resource or our supply chain policy for drugs. Right now, because of the number of patients who need to be on ventilators and need to be sedated because they have a large tube down their throat to give them the ability to breathe, I know that across the country and across the province, we're running short on the medications that are utilized to sedate these patients. We're actually quite anxious about that. Therefore, when I talk about the pharmacare policy, not only am I talking about specific drug plans for individual Canadians so that they can have access to medication if we do find one that is working, but I am also talking about a pharmacare policy that creates and opens supply chains for these very important drugs that we may run out of in the very near future in large hospitals.